|
KMID : 1172020200210010057
|
|
Journal of Korean Bioethics Association
2020 Volume.21 No. 1 p.57 ~ p.70
|
|
|
Necessity and condition of terms for ‘Human Embryo and Germ-line genetic modification’
|
|
Moon Han-Nah
|
|
|
Abstract
|
|
|
|
In terms of modifying DNA information in human cells, various terms are used depending on the purpose, object, method, and result, and the definitions of the terms are different. For example, gene therapy, genetic variation, genetic modification, genome editing. In particular, the terms used in the areas of domestic and foreign laws need to be examined in detail because they reveal differences in regulatory power. It is important to develop a consensus term that have appropriate implications at the present time, as technologies are being developed that can modify genetic information and discussions of research permits for embryos and germ cell subjects are active. Therefore, this paper should summarize the definition of gene therapy that has been used in the law, examine whether it can be used in embryos and germ cells, while referring to overseas cases, I would like to suggest a term suitable for use in Korea. Beginning with this discussion, it is hoped that further discussions on relevant legislative improvements, such as relevant review procedures and regulatory methods, with regard to genetic modifications will be made on the basis of agreed terms in society.
|
|
|
KEYWORD
|
|
|
Gene therapy, Genetic Modification, Human Embryo, Human Germ Cell, Human Germ-Line, Gene editing
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|